title: [INFLUENCE OF REAMBERIN® AND CYCLOFERON® ON CONCETRATION OF "AVERAGE MOLECULES" IN SERUM OF PATIENTS WITH RECCURENT DEPRESSIVE DISORDERS IN OUTPATIENT OBSERVATION].
abstract: The influence Reamberin® and Cycloferon® concentration "average molecules" in the serum of patients with the recurrent depressive disorders (RDD) was investigated. It was set that the use of these drugs helps to normalize the concentration of "average molecules". which indicates that the elimination of the syndrome of "metabolic" intoxication. Based on the data, we can consider it appropriate inclusion Reamberin® and Cycloferon® in the therapeutic treatment of patients with RDR.
authors.forename: I F
authors.initials: IF
authors.lastname: Tereshina
authors.forename: I I
authors.initials: II
authors.lastname: Kut'ko
authors.forename: G S
authors.initials: GS
authors.lastname: Rachkauskas
mesh_terms: D000166:Acridines / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000553:Ambulatory Care / Q000379:methods*; D000928:Antidepressive Agents / Q000008:administration & dosage; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003866:Depressive Disorder / Q000097:blood* / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012008:Recurrence; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000166:Acridines; D000928:Antidepressive Agents; D000975:Antioxidants; D014150:Antipsychotic Agents; D007369:Interferon Inducers; C549374:Reamberin; D013386:Succinates; D008536:Meglumine; C026430:10-carboxymethyl-9-acridanone